Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tepotinib’s Impact on METEX14 NSCLC: DNA, Markers, and Resistance Dec 14, 2023
Bladder Cancer,Genitourinary Cancer Erdafitinib vs. Pembrolizumab in Advanced UC With FGFR Alterations Dec 14, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Tarlatamab in SCLC: Early Results From DeLLphi-301 Trial Dec 14, 2023
Gynecologic Cancer Reversed PORTEC Protocol for Treating High-Risk EC in Low-Resource Settings Dec 13, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Long-Term Benefit of Tafasitamab + Lenalidomide in DLBCL Subgroups Dec 13, 2023